# Sylvia E. Rosas

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sylvia-e-rosas/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,915 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 60 |
| i10-index | 155 |
| Last Known Institution | Joslin Diabetes Center |
| OpenAlex ID | https://openalex.org/A5086540785 |
| ORCID iD | 0000-0002-9903-4002 |
| Works | 270 |

## Researcher papers

- [Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2022-a-consensus-report-by-the/)
- [FGF23 induces left ventricular hypertrophy](https://scholariq.org/papers/fgf23-induces-left-ventricular-hypertrophy/)
- [Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycaemia-in-type-2-diabetes-2022-a-consensus-report-by-the/)
- [Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)](https://scholariq.org/papers/diabetes-management-in-chronic-kidney-disease-a-consensus-report-by-the-american-2/)
- [An atlas of healthy and injured cell states and niches in the human kidney](https://scholariq.org/papers/an-atlas-of-healthy-and-injured-cell-states-and-niches-in-the-human-kidney/)
- [Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes](https://scholariq.org/papers/serum-urate-lowering-with-allopurinol-and-kidney-function-in-type-1-diabetes/)
- [KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)](https://scholariq.org/papers/kdoqi-us-commentary-on-the-2017-kdigo-clinical-practice-guideline-update-for-the/)
- [Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease](https://scholariq.org/papers/coronary-artery-calcification-and-risk-of-cardiovascular-disease-and-death-among/)
- [Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)](https://scholariq.org/papers/diabetes-management-in-chronic-kidney-disease-a-consensus-report-by-the-american/)
- [Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD](https://scholariq.org/papers/associations-between-kidney-function-and-subclinical-cardiac-abnormalities-in/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Finerenone in Type 1 Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/finerenone-in-type-1-diabetes-and-chronic-kidney-disease/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Joslin Diabetes Center](https://scholariq.org/institutions/joslin-diabetes-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.